In this study, our results showed that the high CD26 expression level was a significant predictor of both reduced overall survival (P<0.001, log rank test) and disease free survival (P = 0.001) in patients with CRC under univariate analysis, which means that higher CD26 expression has worse survival rate and higher rate of recurrence. The gene discussed is DPP4; the disease is colorectal carcinoma.